La Jolla Pharmaceutical Company

États‑Unis d’Amérique


 
Quantité totale PI 28
Quantité totale incluant filiales 28 (+ 0 pour les filiales)
Rang # Quantité totale PI 51 484
Note d'activité PI 0,9/5.0    2
Rang # Activité PI 467 807
Symbole boursier LJPC (nasdaq)
ISIN US5034596040
Capitalisation 118M  (USD)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

1 3
0 1
18 1
4
 
Dernier brevet 2021 - Methods of administering hepcidin
Premier brevet 1986 - D-gl conjugate therapy
Dernière marque 2018 - GIAPREZA
Première marque 2017 - LA JOLLA PHARMACEUTICAL

Filiales

1 subsidiaries with IP (0 patents, 0 trademarks)

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2019 Invention Glycolipids as treatment for disease. This invention provides compounds, compositions, and metho...
Invention Methods of treating angioedema. The present disclosure relates to the use of angiotensinogen, ang...
Invention Inhibition of bmp signaling, compounds, compositions and uses thereof. Provided herein are substi...
Invention Compositions comprising hepcidin and methods of use thereof. Provided herein are improved compos...
Invention Compositions comprising hepcidin and methods of use thereof. Provided herein are improved composi...
2018 P/S Pharmaceuticals for the treatment of hypotension; antihypotensive agents.
P/S Pharmaceuticals for the treatment of hypotension; antihypotensive agents
P/S pharmaceuticals; pharmaceutical products for human use.
P/S Pharmaceuticals for the treatment of hypotension; antihypotensive agents; Pharmaceuticals.
Invention Methods of inducing anti-malarial immune responses and compositions related thereto. Provided her...
Invention Metalloporphyrin microparticles for treatment of anemia and tropical diseases. Methods of use for...
Invention Compositions and methods for treating iron overload. The present disclosure relates to the use o...
Invention Compositions and methods for treating iron overload. The present disclosure relates to the use of...
2017 Invention Methods of administering hepcidin. The present disclosure relates to the use of hepcidin in ther...
Invention Methods of administering hepcidin. The present disclosure relates to the use of hepcidin in thera...
P/S pharmaceuticals for the treatment of hypotension; antihypotensive agents
Invention Methods of treating iron overload. Provided herein are compositions and methods related to the u...
Invention Methods of treating iron overload. Provided herein are compositions and methods related to the us...
P/S Pharmaceuticals; pharmaceuticals for the treatment of hypotension; antihypotensive agents.
P/S Pharmaceuticals; pharmaceutical products for human use.
Invention Compositions and methods for treating cancer. The invention provides methods for the treatment of...
Invention Compositions and methods related to gentamicin. Various aspects of the invention relate to compo...
Invention Compositions and methods related to gentamicin. Various aspects of the invention relate to compos...
P/S House mark for pharmaceutical products for human use, namely, pharmaceuticals for the treatment o...
P/S house mark for pharmaceutical products for human use, namely, pharmaceuticals for the treatment o...
Invention Methods for administering angiotensin ii. The present disclosure relates to the use of angiotensi...
Invention Methods of administering vasopressors. The present disclosure relates to the use of angiotensinog...
2016 Invention Composition and uses of galectin antagonists. The present invention is directed to methods and c...
2015 Invention Glycolipids as treatment for disease. This invention provides compounds, compositions, and method...
Invention Methods for treating hypotension. The present disclosure relates to the use of angiotensin II in ...
Invention Mutant endoglycoceramidases with enhanced synthetic activity. The present invention relates to a ...
Invention Hepcidin mimetic peptides and uses thereof. Compounds and methods are described herein that can b...
Invention Compositions and methods for administering galectin antagonists. The invention provides methods ...
Invention Compositions and methods for treating kidney disorders. The invention provides methods for the tr...
2014 Invention Composition and uses of galectin antagonist. The present invention is directed to methods and co...
Invention Modified pectins, compositions and methods related thereto. The present invention provides compos...
Invention Compositions and methods for treating renal failure. The present disclosure relates to the use of...
2013 Invention Treatment of hypoglycemia. This invention provides compounds, compositions, and methods for trea...
Invention Treatment of hypoglycemia. This invention provides compounds, compositions, and methods for treat...
2010 Invention Novel synthetic ganglioside derivatives and compositions thereof. Novel synthetic gangliosides a...